This public procurement record has 4 releases in its history.

TenderUpdate

08 Jul 2025 at 13:43

TenderUpdate

13 Jun 2025 at 10:25

TenderUpdate

19 May 2025 at 08:13

Tender

16 May 2025 at 11:57

Summary of the contracting process

NHS England initiated a tender process to establish Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for melanoma treatment across England, targeting specific geographic regions. The procurement process was open, accommodating various submissions, but was ultimately abandoned on 30th June 2025, as announced by NHS England. Although the process did not result in a contract, significant emphasis was placed on health services, specifically the provision of cellular therapies for previously treated melanoma, aligning with NHS England's Specialised Commissioning goals. Interested parties were originally invited to submit bids by 12:00pm on 24th June 2025, which was later extended to 1st July 2025.

This tendering opportunity, although abandoned, highlighted potential growth areas for businesses specialising in health services, particularly those with expertise in cellular therapies, surgical tissue resection, and care management of interleukin-2 inhibitor effects. Businesses equipped with appropriate Human Tissue Authority licences and working towards or holding JACIE Accreditation were particularly poised to compete effectively. While no contract was awarded, the initiative underscored NHS England's commitment to engaging experienced providers in advancing innovative treatments for melanoma, generating future opportunities as the service continues to develop in line with NICE guidance.

How relevant is this notice?

Notice Title

Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)

Notice Description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England -Specialised Commissioning (referred to as the Authority), is inviting suitably qualified and experienced providers to respond to this Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Lot Information

Lot 1 - London (2 Sites)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with two (2) sites in London.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 2 - East of England (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the East of England.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 3 - South East (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South East.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 4 - South West (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South West.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 5 - Midlands (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the Midlands.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 6 - North East and Yorkshire (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North East and Yorkshire.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Lot 7 - North West (1 Site)

The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North West.

Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered.

Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.

Link to NHS England Regions:
NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).

As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).

The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025.

Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s)

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0515a8
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/038239-2025
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
£69,970,000 £10M-£100M
Lots Value
£69,910,000 £10M-£100M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
8 Jul 20251 years ago
Submission Deadline
24 Jun 2025Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
31 Oct 2025 - 30 Oct 2030 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...